Damir Simic
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Mitochondrial Function and Pathology 3
- Metabolomics and Mass Spectrometry Studies 2
- RNA Interference and Gene Delivery 2
-
- Drug-Induced Ocular Toxicity 2
- Co-authors
- Monicah A. Otieno (4 shared papers)Jan Snoeys (4 shared papers)Teng Fang (2 shared papers)Andries D. van der Meer (1 shared paper)Jacob P. Fraser (1 shared paper)Geraldine A. Hamilton (2 shared papers)Riccardo Barrile (1 shared paper)Mimi Zhou (1 shared paper)
- Journals
- Toxicological Sciences (2 papers)Investigative Ophthalmology & Visual Science (2 papers)Toxicology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Damir Simic
18 papers receiving 271 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 47
- Hepatology 23
- Biomedical Engineering 87
- Hematology 19
- Endocrinology, Diabetes and Metabolism 27
Countries citing papers authored by Damir Simic
This map shows the geographic impact of Damir Simic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damir Simic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damir Simic more than expected).
Fields of papers citing papers by Damir Simic
This network shows the impact of papers produced by Damir Simic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damir Simic. The network helps show where Damir Simic may publish in the future.
Co-authors
The 25 scholars most cited alongside Damir Simic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 98 | |
| 2 | 2017 | 66 | |
| 3 | 2018 | 35 | |
| 4 | 2017 | 12 | |
| 5 | 2019 | 12 | |
| 6 | 2015 | 11 | |
| 7 | 2016 | 10 | |
| 8 | 2006 | 9 | |
| 9 | 2020 | 8 | |
| 10 | 2023 | 4 | |
| 11 | 2013 | 3 | |
| 12 | 2012 | 3 | |
| 13 | 2013 | 2 | |
| 14 | 2019 | 2 | |
| 15 | Early MNU–induced retinal toxicity detected by electroretinography and visual acuity in funduscopically normal rats | 2004 | 1 |
| 16 | Drug-Induced Lens Toxicity and Differential Expression of miRNA | 2008 | 1 |
| 17 | 2014 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2014 | 0 | |
| 20 | 2011 | 0 |
About Damir Simic
Damir Simic is a scholar working on Molecular Biology, Ophthalmology, Clinical Biochemistry, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 279 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (3 papers), Mitochondrial Function and Pathology (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Drug-Induced Ocular Toxicity (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), RNA Interference and Gene Delivery (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pharmacology (47 citations), Hepatology (23 citations), Biomedical Engineering (87 citations), Hematology (19 citations) and Endocrinology, Diabetes and Metabolism (27 citations). Damir Simic has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Monicah A. Otieno, Jan Snoeys, Teng Fang, Andries D. van der Meer, Jacob P. Fraser, Geraldine A. Hamilton, Riccardo Barrile, Mimi Zhou, Donald E. Ingber and Abhishek Jain. Their work appears in journals such as Toxicological Sciences, Investigative Ophthalmology & Visual Science, Toxicology, Clinical Pharmacology & Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.